Sign in

Fortive Corporation FTV

Price 57.6 USD
as of 2026-09-05
45/100
Weak
Quality56
Growth15
Balance-sheet strength45
Valuation51
Momentum48
Income41

Composite 45/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 15/100 — a strong mark against it.

Case for

Quality ranks 56/100 — a slight point in its favour. Valuation ranks 51/100 — a slight point in its favour.

Case against

Growth ranks 15/100 — a strong mark against it. Income ranks 41/100 — a slight mark against it. Balance-sheet strength ranks 45/100 — a slight mark against it.

What the company does Fortive designs and markets advanced instrumentation, software, and services under brands such as FLUKE and PROVATION. Its Intelligent Operating Solutions segment serves manufacturing and process industries, while Advanced Healthcare Solutions focuses on clinical workflow and safety monitoring.

Key financials Revenue declined 17.5% and EPS fell 23.2%. Margins remain healthy at 63.2% gross, 19.1% operating, and 12.4% net. Debt/Equity is 0.59 with net debt/EBITDA at 2.61, and FCF yield is 5.5%.

Stock health Sideravia scores the stock Average quality with a 44.0 overall. Growth is weak at 15.6, while Valuation is fairly valued at 42.8. RSI(14) is 32.70, indicating oversold conditions.

Price vs fair value The stock trades at a discount of 13.60% versus the analyst mean target of 64.31. - Recent product launches (Fluke ii01 Acoustic Camera, Sep 2) may boost long-term demand. - Expansion of engineering lab (Sep 3) supports talent pipeline and brand visibility. - Fortive’s presence at Morgan Stanley Laguna Conference (Sep 1) signals investor interest.

Looking forward Forward P/E of 19.76 and PEG of 0.32 suggest potential valuation support, but weak growth (15.6) and modest momentum (47.4) temper near-term outlook.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.